The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling
- 17 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 17 (5), 596-603
- https://doi.org/10.1038/nm.2356
Abstract
Chronic inflammation of the airways is associated with remodeling and fibrosis, leading to a progressive decline in lung function in people with severe asthma. Michael Croft and his colleagues report that in mouse models of allergic lung inflammation expression of the TNF family member LIGHT is induced. Blockade of LIGHT prevents remodeling, providing a therapeutic strategy to prevent asthmatic airway remodeling. Individuals with chronic asthma show a progressive decline in lung function that is thought to be due to structural remodeling of the airways characterized by subepithelial fibrosis and smooth muscle hyperplasia. Here we show that the tumor necrosis factor (TNF) family member LIGHT is expressed on lung inflammatory cells after allergen exposure. Pharmacological inhibition of LIGHT using a fusion protein between the IgG Fc domain and lymphotoxin β receptor (LTβR) reduces lung fibrosis, smooth muscle hyperplasia and airway hyperresponsiveness in mouse models of chronic asthma, despite having little effect on airway eosinophilia. LIGHT-deficient mice also show a similar impairment in fibrosis and smooth muscle accumulation. Blockade of LIGHT suppresses expression of lung transforming growth factor-β (TGF-β) and interleukin-13 (IL-13), cytokines implicated in remodeling in humans, whereas exogenous administration of LIGHT to the airways induces fibrosis and smooth muscle hyperplasia, Thus, LIGHT may be targeted to prevent asthma-related airway remodeling.This publication has 60 references indexed in Scilit:
- Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytesJournal of Allergy and Clinical Immunology, 2010
- TGF-β1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1β but not abrogated by corticosteroidsRespiratory Research, 2009
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cellsNature Medicine, 2009
- CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodelingAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Transcriptome profiling of primary murine monocytes, lung macrophages and lung dendritic cells reveals a distinct expression of genes involved in cell traffickingRespiratory Research, 2009
- In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammationJCI Insight, 2007
- Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometryJournal of Immunological Methods, 2007
- IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17Respiratory Research, 2007
- Expression of lymphotoxin-αβ on antigen-specific T cells is required for DC functionThe Journal of Experimental Medicine, 2007